North China Pharmaceutical Company.Ltd

600812

CNE000000D16

Pharmaceuticals

End-of-day quote Shanghai S.E. Other stock markets 06:00:00 2024-04-25 pm EDT			5-day change	1st Jan Change
4.91 ^CNY	+3.81%		+9.84%	-13.86%

Apr. 25	North China Pharmaceutical Company.Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Mar. 30	North China Pharmaceutical Company.Ltd agreed to acquire the remaining 35.85% stake in NCPC Hebei Huamin Pharmaceutical Co., Ltd. from CCB Financial Asset Investment Co., Ltd. for CNY 670 million	CI

North China Pharmaceutical Company.Ltd(XSSC:600812) added to S&P Global BMI Index

September 18, 2023 at 12:00 am EDT

Latest news about North China Pharmaceutical Company.Ltd

North China Pharmaceutical Company.Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 25	CI
North China Pharmaceutical Company.Ltd agreed to acquire the remaining 35.85% stake in NCPC Hebei Huamin Pharmaceutical Co., Ltd. from CCB Financial Asset Investment Co., Ltd. for CNY 670 million	Mar. 29	CI
North China Pharmaceutical Company.Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 29	CI
North China Pharmaceutical Subsidiary Gets Europe's Compliance Certification for Drug Raw Material	Feb. 27	MT
Jizhong Energy Group Finance Co., Ltd announced that it has received CNY 1.3 billion in funding from Jizhong Energy Group Co.,Ltd., Jizhong Energy Resources Co., Ltd., North China Pharmaceutical Company.Ltd	Dec. 05	CI
North China Pharmaceutical Gets Nod to Market Ampicillin API	Nov. 20	MT
North China Pharmaceutical Company.Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-26	CI
North China Pharmaceutical Company.Ltd(XSSC:600812) added to S&P Global BMI Index	23-09-18	CI
North China Pharmaceutical Company.Ltd(XSSC:600812) added to FTSE All-World Index	23-09-18	CI
North China Pharmaceutical Company.Ltd Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-18	CI
Jizhong Energy Group Finance Co., Ltd announced that it expects to receive CNY 1.3 billion in funding from Jizhong Energy Group Co.,Ltd., Jizhong Energy Resources Co., Ltd., North China Pharmaceutical Company.Ltd	23-08-16	CI
North China Pharmaceutical Company Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-26	CI
North China Pharma Unit Passes Compliance Inspection	23-03-31	MT
North China Pharmaceutical's Heart Drug Passes Regulatory Evaluation	23-02-13	MT
North China Pharmaceutical Company Ltd.(SHSE:600812) dropped from Shanghai Stock Exchange Health Care Sector Index	22-12-09	CI
North China Pharmaceutical Company Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-26	CI
North China Pharmaceutical Company Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-27	CI
North China Pharmaceutical Company Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	22-04-27	CI
China Rolls Out New Rules to Fight Monopoly in API Drugmaking Market	21-11-18	MT
North China Pharmaceutical Company Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021	21-10-22	CI
North China Pharmaceutical Company Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021	21-08-24	CI
Chinese vitamin C price-fixing lawsuit thrown out by U.S. appeals court	21-08-10	RE
North China Pharmaceutical Company Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021	21-04-28	CI
North China Pharmaceutical Company Ltd. announced a financing transaction	21-03-26	CI
North China Pharmaceutical Company. Ltd completed the acquisition of North China Pharmaceutical Group Corporation Veterinary Co., Ltd., from North China Pharmaceutical Group Corp.	20-12-01	CI

Chart North China Pharmaceutical Company.Ltd

Duration

Period

Chart North China Pharmaceutical Company.Ltd

More charts

North China Pharmaceutical Co Ltd is a China-based company primarily engaged in the research, development, production and sales of pharmaceutical products. The Company's main products include anti-infective drugs, nephrology and immunomodulatory drugs, biotechnology drugs, cardiovascular and cerebrovascular and immunomodulatory agents, vitamins and health consumer products, nervous and blood system drugs, pharmaceutical intermediates, anti-epidemic drugs, pesticides and Veterinary drugs. The Company is also engaged in pharmaceutical and other logistics trade pharmaceuticals. The Company's products are mainly used in chemical pharmaceuticals, modern biotechnology drugs, vitamins and health consumer products, bioagricultural and veterinary drugs and other fields. The Company mainly conducts its businesses in domestic and overseas markets.

Sector

Pharmaceuticals

Calendar

2024-08-11 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
NORTH CHINA PHARMACEUTICAL COMPANY.LTD	-13.86%	1.16B
ELI LILLY AND COMPANY	+25.83%	661B
NOVO NORDISK A/S	+27.00%	566B
JOHNSON & JOHNSON	-6.76%	352B
MERCK & CO., INC.	+20.34%	332B
ABBVIE INC.	+3.00%	283B
ASTRAZENECA PLC	+13.09%	231B
NOVARTIS AG	+5.46%	200B
ROCHE HOLDING AG	-9.61%	195B
AMGEN INC.	-6.26%	145B